These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2147104)

  • 41. Anti-HIV activity of cosalane.
    Choo V
    Lancet; 1993 Sep; 342(8873):733. PubMed ID: 8103830
    [No Abstract]   [Full Text] [Related]  

  • 42. Hairy cells possess more interferon receptors than other lymphoid cell types.
    Dadmarz R; Evans T; Secher D; Marshall N; Cawley JC
    Leukemia; 1987 Apr; 1(4):357-61. PubMed ID: 2959825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions.
    Guo Q; Ho HT; Dicker I; Fan L; Zhou N; Friborg J; Wang T; McAuliffe BV; Wang HG; Rose RE; Fang H; Scarnati HT; Langley DR; Meanwell NA; Abraham R; Colonno RJ; Lin PF
    J Virol; 2003 Oct; 77(19):10528-36. PubMed ID: 12970437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
    Hertzog PJ; Johns TG; Callister KA; Dinatale A; Linnane AW
    Biochem Int; 1990 Dec; 22(6):1095-102. PubMed ID: 2151021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
    Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
    Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Procedures for binding an antibody to receptor-bound interferon.
    Arnheiter H; Zoon KC
    Methods Enzymol; 1986; 119():326-32. PubMed ID: 2945074
    [No Abstract]   [Full Text] [Related]  

  • 47. Kinetics of receptor-mediated uptake and processing of interferon-alpha 2a and tumor necrosis factor-alpha by human tumor cells.
    Dunne SL; Bajzer Z; Vuk-Pavlović S
    Growth Factors; 1990; 2(2-3):167-77. PubMed ID: 2160259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.
    Liu L; Patel B; Ghanem MH; Bundoc V; Zheng Z; Morgan RA; Rosenberg SA; Dey B; Berger EA
    J Virol; 2015 Jul; 89(13):6685-94. PubMed ID: 25878112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Receptors for human alpha interferon: are gangliosides involved?
    Gupta SL; Raziuddin A; Sarkar FH
    J Interferon Res; 1984; 4(3):305-14. PubMed ID: 6238109
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aurintricarboxylic acid induces a distinct activation of the IGF-I receptor signaling within MDA-231 cells.
    Haimsohn M; Beery R; Karasik A; Kanety H; Geier A
    Endocrinology; 2002 Mar; 143(3):837-45. PubMed ID: 11861505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aurintricarboxylic acid decreases proliferative potential of SKOV3 and MCF7 human carcinoma cells.
    Fraifeld V; Seidman R; Sagi O; Muradian K; Wolfson M
    Anticancer Res; 2001; 21(3B):1975-8. PubMed ID: 11497286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extraction of alpha interferon-receptor complexes with digitonin.
    Eid P; Mogensen KE
    Methods Enzymol; 1986; 119():347-51. PubMed ID: 2945076
    [No Abstract]   [Full Text] [Related]  

  • 53. Procedures for studying the binding of interferon to human and bovine cells in monolayer culture.
    Zoon KC; Zur Nedden D; Arnheiter H
    Methods Enzymol; 1986; 119():312-5. PubMed ID: 2945072
    [No Abstract]   [Full Text] [Related]  

  • 54. Aurin tricarboxylic acid inhibits fibrinogen clotting with thrombin by forming soluble fibrin complexes.
    Lipinski B
    Thromb Res; 1995 Feb; 77(4):379-80. PubMed ID: 7740529
    [No Abstract]   [Full Text] [Related]  

  • 55. The cellular receptor of the alpha-beta interferons.
    Mogensen KE; Uzé G; Eid P
    Experientia; 1989 Jun; 45(6):500-8. PubMed ID: 2525481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Interferon-alpha/beta receptor in patients with HBV].
    Kurai O; Nakajima S; Kuroki T; Shintani M; Nishiguchi S; Shiomi S; Kobayashi K; Monna T
    Nihon Shokakibyo Gakkai Zasshi; 1989 Mar; 86(3):808. PubMed ID: 2528010
    [No Abstract]   [Full Text] [Related]  

  • 57. Shared architecture of hormone binding domains in type I and II interferon receptors.
    Bazan JF
    Cell; 1990 Jun; 61(5):753-4. PubMed ID: 2140527
    [No Abstract]   [Full Text] [Related]  

  • 58. Toxicology of aurin tricarboxylic acid and its antidotal effectiveness against beryllium.
    KING ME
    ASD Tech Rep; 1961 Dec; 61(674):23. PubMed ID: 24546958
    [No Abstract]   [Full Text] [Related]  

  • 59. A general method for discovering inhibitors of protein-DNA interactions using photonic crystal biosensors.
    Chan LL; Pineda M; Heeres JT; Hergenrother PJ; Cunningham BT
    ACS Chem Biol; 2008 Jul; 3(7):437-48. PubMed ID: 18582039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene expression-based screening for inhibitors of PDGFR signaling.
    Antipova AA; Stockwell BR; Golub TR
    Genome Biol; 2008; 9(3):R47. PubMed ID: 18312689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.